Qual é o preço para Pascal Biosciences Inc. (PSCBF)

O preço para Pascal Biosciences Inc. (PSCBF) é $0.1

Qual é a capitalização de mercado para Pascal Biosciences Inc. (PSCBF)

A capitalização de mercado para Pascal Biosciences Inc. (PSCBF) é $1.31M

Pascal Biosciences Inc. (PSCBF) Ações em Circulação

Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to discovering and advancing therapeutic solutions for oncology and bolstering immune system function. The company's robust pipeline includes several key candidates: PAS-403, a potent mitosis inhibitor designed to impede cancerous cell division, specifically targeting glioblastoma and secondary brain tumors; and PAS-393, an immunomodulatory cannabinoid developed to enhance the immune system's recognition of tumor cells when utilized alongside checkpoint inhibitor therapy. Furthermore, Pascal is progressing a specialized antibody therapy aimed at B-cells, intended for conditions like acute lymphoblastic leukemia and various B-cell lymphomas. The company is also investigating cannabinoid-derived products as potential treatments for COVID-19. To support its research, Pascal Biosciences maintains an exclusive licensing agreement with the University of Washington for a cannabinoid-based therapeutic against glioblastoma multiforme and brain metastases. It also benefits from a collaborative research partnership with SoRSE Technology Corporation, focused on advancing PAS-393 toward clinical trials. Founded in 2011, the company operates from its headquarters in Seattle, Washington.

Ano	Ações em circulação	Alterar
2026 (TTM)	38.14M	62.10%
2023	23.53M	79.48%
2022	13.11M	3.25%
2021	12.70M	14.59%
2020	11.08M	5.23%
2019	10.53M	0.00%

Ano

Ações em circulação

Alterar

2026 (TTM)

38.14M

62.10%

2023

23.53M

79.48%

2022

13.11M

3.25%

2021

12.70M

14.59%

2020

11.08M

5.23%

2019

10.53M

0.00%

Empresa	Ações em circulação	Diferença	País
Vertex Pharmaceuticals Incorporated VRTX.US	253.90M	565.70%	US
Argenx SE ARGX.US	62.19M	63.04%	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	0.00	-100.00%	BE

Empresa

Ações em circulação

Diferença

País